2018
DOI: 10.3343/alm.2018.38.6.591
|View full text |Cite
|
Sign up to set email alerts
|

Association of FOXP3 Single Nucleotide Polymorphisms With Clinical Outcomes After Allogenic Hematopoietic Stem Cell Transplantation

Abstract: BackgroundForkhead box P3 (FOXP3) is an important marker of regulatory T cells. FOXP3 polymorphisms are associated with autoimmune diseases, cancers, and allograft outcomes. We examined whether single nucleotide polymorphisms (SNPs) at the FOXP3 locus are associated with clinical outcomes after allogenic hematopoietic stem cell transplantation (HSCT).MethodsFive FOXP3 SNPs (rs5902434, rs3761549, rs3761548, rs2232365, and rs2280883) were analyzed by PCR-sequencing of 172 DNA samples from allogenic HSCT patients… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
6
1

Year Published

2019
2019
2023
2023

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(7 citation statements)
references
References 40 publications
0
6
1
Order By: Relevance
“…SNPs have been identified as risk factors for AML development [115,116,117] and as prognostic factors in terms of survival outcomes and drug sensitivity/resistance [118,119,120,121]. FOXP3 SNPs have been recently identified as prognostic factors in pediatric and adult patients undergoing HSCT [122]. A comprehensive study of FOX family members SNPs may be another attractive and informative research field in AML.…”
Section: Future Perspectivesmentioning
confidence: 99%
“…SNPs have been identified as risk factors for AML development [115,116,117] and as prognostic factors in terms of survival outcomes and drug sensitivity/resistance [118,119,120,121]. FOXP3 SNPs have been recently identified as prognostic factors in pediatric and adult patients undergoing HSCT [122]. A comprehensive study of FOX family members SNPs may be another attractive and informative research field in AML.…”
Section: Future Perspectivesmentioning
confidence: 99%
“…Currently, preemptive therapy-based monitoring of CMV viremia is performed to improve CMV-related outcomes [5]. The range of CMV infection after HSCT can be different because HSCT patients have diverse CMV serostatus, different CMV prophylaxis, conditioning methods, genetic polymorphism, and inconstant post-HSCT immune reconstitution against CMV infection [5,7,9,11,12]. Considering these differences, CMV-specific immunity plays a vital role in controlling CMV reactivation and disease development.…”
Section: Introductionmentioning
confidence: 99%
“…AA genotype of rs3761548 leads to loss of binding sites for TFs E47 and C-Myb [ 34 ]. Moreover, the GG genotype for rs2232365 and TT genotype for rs3761549 lead to loss of binding site for GATA3, activating enhancer-binding protein 4 (AP4) TFs, respectively [ 26 , 33 ]. The affection of FOXP3 protein in quality or quantity leads to Treg cell dysfunction and impairs the balance between Th1 and Th2 cells, disturbing the immune system’s balance toward the development of immunological and autoimmune diseases [ 41 ].…”
Section: Discussionmentioning
confidence: 99%
“…In HSCT, rs3761548 CC genotype was associated with veno-occlusive disease and cytomegalovirus (CMV) infection but no evidence of association with graft-versus-host disease (GVHD) or relapse [ 37 ]. Nam et al [ 33 ], on the other hand, did not find an association with allogenic HSCT outcomes. In renal transplantation, decreased overall surveillance was associated with rs361548 and rs2232365 mutant genotypes compared with the wild one [ 32 ].…”
Section: Discussionmentioning
confidence: 99%